ISA Pharmaceuticals B.V. is an immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections. The Company has built a proprietary immunotherapy platform based on the Synthetic Long Peptide (SLP®) concept and AMPLIVANT®technology.

Biotechnology

ISA Pharmaceuticals

Gerben Moolhuizen

Marie-Andrée Yessine

Lisette Bevaart

Anna-Sophia Wiekmeijer

Leon Hooftman

Kees Melief

Willem-Jan Krebber

The Scientific Research Team at ISA Pharmaceuticals focuses on advancing the company's immunotherapy pipeline by conducting in-depth research into synthetic immunotherapeutics. This team, consisting of experts in immunology and immunomonitoring, collaborates to design and evaluate innovative therapeutic candidates based on the SLP® and AMPLIVANT® platforms. Their goal is to enhance understanding of immune responses and optimize treatments for cancer and viral infections.

Scientific Research Team

Project Management

Business Development and Strategy

Scientific Research Team

About

Team members

Other teams at ISA Pharmaceuticals

Project Management

Business Development and Strategy